1st Quarter - Report

ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS

Period 1st Quarter 2020 Filed Apr 20, 2020 Signed by Alisa Jane Maso, Chief of Staff

Official filing
Firm
ALPINE GROUP PARTNERS, LLC.
Client
EMERGENT BIOSOLUTIONS
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines

LobbyistCovered position, as disclosed
COURTNEY JOHNSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations Provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government

LobbyistCovered position, as disclosed
COURTNEY JOHNSON —
NEAL PATEL COS to Deputy Dir. for Mgmt., OMB (EOP); Deputy Assoc. Dir. for Leg Affairs, OMB (EOP); Professional Staff Member, Senate Finance Cmte; Communications Dir. & Counsel, Senator Dean Heller; Communications Dir. & Counsel, Rep. Charles Boustany, Jr.; Com

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6074 (116th), S. 3548 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.